Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 4 Planned sale Director sold 20,000 shares at an average $67.31 ($1,346,106)
  7. 144 Insider Sale of Securities
  8. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 642 shares at $66.37 ($42,610)
  9. 4 Planned sale Director sold 10,000 shares at an average $63.28 ($632,846)
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. SCHEDULE 13G Stake Statement of Beneficial Ownership
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 8-K Event Executive or director change
  19. 4 Gift CHIEF MEDICAL OFFICER gave 468 shares (gift)
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 2 of 65 · 1,286 filings